{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:01:27Z","timestamp":1780142487671,"version":"3.54.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejim.2026.106763","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:29:26Z","timestamp":1771417766000},"page":"106763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pitfalls of autoimmune serological markers and practical diagnostic workflows in connective tissue diseases and rheumatoid arthritis"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-7904","authenticated-orcid":false,"given":"Chiara","family":"Bellocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106763_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953726","article-title":"Autoantibodies - enemies, and\/or potential allies?","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0003","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/joim.13472","article-title":"Choosing wisely in clinical practice: embracing critical thinking, striving for safer care","volume":"291","author":"Furlan","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.04.003","article-title":"New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics?","author":"Parodis","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106763_bib0005","series-title":"Pross S. Immunoglobulins. xPharm: the comprehensive pharmacology reference","first-page":"1","author":"Grattendick","year":"2007"},{"key":"10.1016\/j.ejim.2026.106763_bib0006","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjmed.2012.09.014","article-title":"The clinical utility of a positive antinuclear antibody test result","volume":"126","author":"Abeles","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0025-6196(25)10643-5","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell","volume":"23","author":"Hargraves","year":"1948","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.ejim.2026.106763_bib0008","unstructured":"N.d. https:\/\/rheumatology.org\/patients\/antinuclear-antibodies-ana 2025."},{"key":"10.1016\/j.ejim.2026.106763_bib0009","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106763_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","volume":"27","author":"Wandstrat","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2026.106763_bib0011","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/23744235.2019.1690676","article-title":"Antinuclear antibodies in infectious diseases","volume":"52","author":"Im","year":"2020","journal-title":"Infect Dis"},{"key":"10.1016\/j.ejim.2026.106763_bib0013","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.43032","article-title":"Genetic analysis of asymptomatic antinuclear antibody production","volume":"77","author":"Hocao\u01e7lu","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0014","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3121\/cmr.3.3.190","article-title":"Serologic testing in connective tissue diseases","volume":"3","author":"DE","year":"2005","journal-title":"Clin Med Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106763_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13317-016-0075-0","article-title":"International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results","volume":"7","author":"Damoiseaux","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.ejim.2026.106763_bib0017","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5858\/2000-124-0071-GFCUOT","article-title":"Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens","volume":"124","author":"Kavanaugh","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0018","series-title":"Quality assurance of laboratory tests for autoantibodies to nuclear antigens : (1) Indirect fluorescence assay for microscopy and (2) Microtiter enzyme immunoassay methods : approved guideline ; Marilyn M. Lightfoote. [et al.]","author":"Lightfoote","year":"2006"},{"issue":"1","key":"10.1016\/j.ejim.2026.106763_bib0019","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-4-1","article-title":"Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited","volume":"4","author":"Kumar","year":"2009","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ejim.2026.106763_bib0020","first-page":"34","article-title":"Antinuclear antibodies by indirect immunofluorescence : optimum screening dilution for diagnosis of systemic lupus erythematosus","volume":"126","author":"Ghosh","year":"2007","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2011.06.006","article-title":"Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results","volume":"11","author":"Bonaguri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0022","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0023","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/acr.23292","article-title":"Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data","volume":"70","author":"Leuchten","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0024","unstructured":"N.d. https:\/\/www.anapatterns.org 2025."},{"key":"10.1016\/j.ejim.2026.106763_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the international consensus on ANA patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0026","unstructured":"N.d. https:\/\/anapatterns.org\/trees-2021.php 2025."},{"key":"10.1016\/j.ejim.2026.106763_bib0027","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/BOR.0000000000000904","article-title":"Scleroderma autoantibodies in guiding monitoring and treatment decisions","volume":"34","author":"Shah","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/703759","article-title":"Clinical phenotypes of patients with anti-DFS70\/LEDGF antibodies in a routine ANA referral cohort","volume":"2013","author":"Miyara","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.30078","article-title":"The antinuclear antibody test: Last or lasting gasp?","volume":"63","author":"Fritzler","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106763_bib0030","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.3390\/jcm14155322","article-title":"The art of interpreting antinuclear antibodies (ANAs) in everyday practice","volume":"14","author":"K\u0105dziela","year":"2025","journal-title":"JCM"},{"key":"10.1016\/j.ejim.2026.106763_bib0031","first-page":"1","article-title":"Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"2014","author":"Mahler","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0032","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1515\/CCLM.2004.235","article-title":"Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay","volume":"42","author":"Bernardini","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0033","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1038\/s41598-021-87366-w","article-title":"Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases","volume":"11","author":"Alsaed","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2026.106763_bib0034","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/cclm-2020-0094","article-title":"A hierarchical bivariate meta-analysis of diagnostic test accuracy to provide direct comparisons of immunoassays vs. indirect immunofluorescence for initial screening of connective tissue diseases","volume":"59","author":"Orme","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.11613\/BM.2021.020502","article-title":"Assessment of antinuclear antibodies (ANA): national recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine","volume":"31","author":"Te\u0161ija Kuna","year":"2021","journal-title":"Biochem Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0036","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-1759(91)90369-Q","article-title":"The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases","volume":"140","author":"van Venrooij","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejim.2026.106763_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.9.1.1-7.2002","article-title":"Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful","volume":"9","author":"Phan","year":"2002","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0038","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/art.1780390626","article-title":"Utility of anti-Sm, anti-RNP, anti-Ro\/SS-A, and anti-La\/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus","volume":"39","author":"S\u00e1nchez-Guerrero","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106763_bib0039","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00915286","article-title":"Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes","volume":"4","author":"Reichlin","year":"1984","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/CDLI.7.3.436-443.2000","article-title":"Development of the antinuclear and anticytoplasmic antibody consensus panel by the association of medical laboratory immunologists","volume":"7","author":"James","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0041","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1098-2825(1998)12:5<320::AID-JCLA13>3.0.CO;2-X","article-title":"Evaluation of a line immunoblot assay for detection of antibodies recognizing extractable nuclear antigens","volume":"12","author":"Prince","year":"1998","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ejim.2026.106763_bib0042","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2015.10.007","article-title":"Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years","volume":"15","author":"Selmi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113297","article-title":"Current technologies for anti-ENA antibody detection: state-of-the-art of diagnostic immunoassays","volume":"507","author":"Infantino","year":"2022","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejim.2026.106763_bib0044","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/acr.24990","article-title":"Frequency and clinical utility of antibodies to extractable nuclear antigen in the setting of a negative antinuclear antibody test","volume":"75","author":"Yeo","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jcp.54.5.413","article-title":"Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells?","volume":"54","author":"Thomson","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2026.106763_bib0046","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0047","first-page":"243","article-title":"Demonstration in the blood of patients with disseminated lupus erythematosus a substance determining a precipitation reaction with desoxyribonucleic acid]","volume":"245","author":"Seligmann","year":"1957","journal-title":"C R Hebd Seances Acad Sci"},{"key":"10.1016\/j.ejim.2026.106763_bib0048","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3181\/00379727-96-23544","article-title":"A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus","volume":"96","author":"Ceppellini","year":"1957","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus \u2013 A proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0050","unstructured":"N.d. https:\/\/www.the-rheumatologist.org\/article\/know-your-labs\/3\/?singlepage=1 2025."},{"key":"10.1016\/j.ejim.2026.106763_bib0051","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.berh.2015.04.007","article-title":"Cost-effective use of investigations in developing countries","volume":"28","author":"Malaviya","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100139","article-title":"Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus","volume":"5","author":"Infantino","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.ejim.2026.106763_bib0053","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12026-018-8992-9","article-title":"Analytical variability in the determination of anti-double-stranded DNA antibodies: the strong need of a better definition of the old and new tests","volume":"66","author":"Infantino","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0054","article-title":"Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort","volume":"16","author":"Lu","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2004.02085.x","article-title":"Cellular immune responses in autoimmune thyroid disease","volume":"61","author":"Weetman","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2026.106763_bib0056","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6895146","article-title":"Exploring systemic autoimmunity in thyroid disease subjects","author":"Siriwardhane","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0058","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.1780230204","article-title":"A screening strategy for population studies in systemic lupus erythematosus. Series design","volume":"23","author":"Liang","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106763_bib0059","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2397198319826467","article-title":"Raynaud\u2019s phenomenon","volume":"4","author":"Herrick","year":"2019","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.ejim.2026.106763_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0061","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/OARRR.S285409","article-title":"Predicting the progression of very early systemic sclerosis: current insights","volume":"14","author":"Bellocchi","year":"2022","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0062","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Beh\u00e7et\u2019s disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0063","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1532-3382(12)70051-9","article-title":"Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management","volume":"12","author":"Mays","year":"2012","journal-title":"J Evid Based Dent Pract"},{"key":"10.1016\/j.ejim.2026.106763_bib0064","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","article-title":"Autoantibodies in rheumatoid arthritis: historical background and novel findings","volume":"63","author":"Sokolova","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2026.106763_bib0066","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106763_bib0067","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0068","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.38383","article-title":"Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen","volume":"66","author":"Haag","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0069","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0070","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/acr.22385","article-title":"Effects of smoking and shared epitope on the production of anti\u2013citrullinated peptide antibody in a Japanese adult population","volume":"66","author":"Terao","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ejim.2026.106763_bib0071","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-016-1177-9","article-title":"Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study","volume":"18","author":"Van Wesemael","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2026.106763_bib0072","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/03009749509099303","article-title":"IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?","volume":"24","author":"van Leeuwen","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0073","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles","volume":"17","author":"Waaler","year":"1940","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.ejim.2026.106763_bib0074","article-title":"Measurement of IgM rheumatoid factor by ELISA","volume":"30","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0075","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/art.1780340804","article-title":"The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients","volume":"34","author":"Wolfe","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106763_bib0076","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/ard.44.6.379","article-title":"Routine quantification of rheumatoid factor by rate nephelometry","volume":"44","author":"Roberts-Thomson","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106763_bib0077","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/clinchem\/32.10.1890","article-title":"Evaluation of a quantitative immunoturbidimetric assay for rheumatoid factors","volume":"32","author":"Melamies","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2026.106763_bib0078","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.3390\/ijerph17218054","article-title":"Levels of anti-citrullinated protein antibodies and rheumatoid factor, including IgA isotypes, and articular manifestations in ulcerative colitis and Crohn\u2019s disease","volume":"17","author":"Janssen","year":"2020","journal-title":"IJERPH"},{"key":"10.1016\/j.ejim.2026.106763_bib0079","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.autrev.2011.11.011","article-title":"Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases","volume":"11","author":"Palazzi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9343(91)90190-9","article-title":"The rheumatoid factor: an analysis of clinical utility","volume":"91","author":"Shmerling","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0081","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/rheumatology\/kep314","article-title":"Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis","volume":"48","author":"Quartuccio","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2026.106763_bib0082","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejim.2026.106763_bib0083","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0084","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/biom13020367","article-title":"Complement as a biomarker for systemic lupus erythematosus","volume":"13","author":"Ayano","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejim.2026.106763_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102655","article-title":"Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functions","volume":"97","author":"Clavarino","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0086","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/keu343","article-title":"Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus","volume":"54","author":"Ishizaki","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2026.106763_bib0087","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tmrv.2019.08.002","article-title":"The role of complement in hereditary angioedema","volume":"33","author":"Levi","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0088","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0089","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.medj.2024.06.005","article-title":"Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: a cluster analysis based on CSTAR cohort","volume":"5","author":"Ding","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","article-title":"Approach to asymptomatic creatine kinase elevation","volume":"83","author":"Moghadam-Kia","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0091","first-page":"383","article-title":"Diagnostic value of creatine phosphokinase (CPK) isoenzymes in the absence of elevated total CPK","volume":"71","author":"Ruff","year":"1979","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ejim.2026.106763_bib0092","series-title":"Patel R. Creatine Phosphokinase. StatPearls, Treasure Island (FL)","author":"Aujla","year":"2025"},{"key":"10.1016\/j.ejim.2026.106763_bib0093","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s13181-010-0075-9","article-title":"Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury","volume":"6","author":"Weibrecht","year":"2010","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.ejim.2026.106763_bib0094","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.ejim.2026.106763_bib0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0096","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0097","first-page":"105","article-title":"Understanding and interpreting serum protein electrophoresis","volume":"71","author":"O\u2019Connell","year":"2005","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.ejim.2026.106763_bib0098","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000212077","article-title":"Serum protein electrophoresis: an underused but very useful test","volume":"79","author":"Vavricka","year":"2009","journal-title":"Digestion"},{"key":"10.1016\/j.ejim.2026.106763_bib0099","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1200\/JCO.22.01916","article-title":"Definition and clinical significance of the monoclonal gammopathy of undetermined significance-like phenotype in patients with monoclonal gammopathies","volume":"41","author":"Burgos","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2026.106763_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103895","article-title":"Monoclonal gammopathy of rheumatologic significance (MGRhS): a systemic vision of clonal disorders with multiple organ involvement","volume":"24","author":"Quartuccio","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0101","first-page":"1835","article-title":"The etiology and management of leukopenia","volume":"30","author":"Ing","year":"1984","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.ejim.2026.106763_bib0102","unstructured":"Lam L., Mumford J., Keber B., Flanagan B. Hematologic conditions: leukopenia. FP. Essent. 2019;485:11\u20136."},{"key":"10.1016\/j.ejim.2026.106763_bib0103","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semarthrit.2015.05.009","article-title":"Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: prevalence and clinical impact\u2013A systematic literature review","volume":"45","author":"Carli","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106763_bib0104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.31138\/mjr.33.1.99","article-title":"Clinical phenotype and mechanisms of leukopenia\/neutropenia in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"33","author":"Stergiou","year":"2022","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0105","doi-asserted-by":"crossref","unstructured":"Rodolfi S., Lleo A. Autoimmune leukopenia. The rose and Mackay textbook of autoimmune diseases, Elsevier; 2024, p. 549\u201358. 10.1016\/B978-0-443-23947-2.00011-4.","DOI":"10.1016\/B978-0-443-23947-2.00011-4"},{"key":"10.1016\/j.ejim.2026.106763_bib0106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2009.03.006","article-title":"Autoimmune neutropenia in adults","volume":"9","author":"Akhtari","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106763_bib0107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(91)90544-8","article-title":"Idiopathic neutropenia: antineutrophil antibodies and clinical correlations","volume":"90","author":"Logue","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations","volume":"69","author":"Campion","year":"1990","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2026.106763_bib0109","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12876-023-02829-w","article-title":"Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals","volume":"23","author":"Tajiri","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2026.106763_bib0110","doi-asserted-by":"crossref","first-page":"119S","DOI":"10.1002\/j.1875-9114.1991.tb02641.x","article-title":"Complications associated with immunosuppressive therapy and their management","volume":"11","author":"Min","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2026.106763_bib0111","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0112","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0113","series-title":"Justiz Vaillant AA, Pearson-Shaver AL. Immune thrombocytopenia. StatPearls, treasure Island (FL)","author":"Pietras","year":"2025"},{"key":"10.1016\/j.ejim.2026.106763_bib0114","series-title":"Qurie A. Lupus Nephritis. StatPearls, treasure Island (FL)","author":"Musa","year":"2025"},{"key":"10.1016\/j.ejim.2026.106763_bib0115","first-page":"1557","article-title":"Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis","volume":"31","author":"Christopher-Stine","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106763_bib0116","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/diseases11040132","article-title":"Protein: pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians","volume":"11","author":"C-Reactive","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.ejim.2026.106763_bib0117","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0118","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","article-title":"Function of C-reactive protein","volume":"32","author":"Du Clos","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.ejim.2026.106763_bib0119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1309\/QB1G-6FRR-DNWX-BKQ9","article-title":"Erythrocyte sedimentation rate: use of fresh blood for quality control","volume":"117","author":"Plebani","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejim.2026.106763_bib0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jlb.53.4.439","article-title":"C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages","volume":"53","author":"Galve-de Rochemonteix","year":"1993","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ejim.2026.106763_bib0121","article-title":"C-reactive protein: structure, function, regulation, and role in clinical diseases","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2026.106763_bib0122","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.0954-6820.1953.tb10229.x","article-title":"Studies on factors influencing erythrocyte sedimentation rate","volume":"146","author":"Martensson","year":"1953","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejim.2026.106763_bib0123","series-title":"Cryoglobulinemia. StatPearls, treasure Island (FL)","author":"Killeen","year":"2025"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:10:38Z","timestamp":1780139438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":123,"alternative-id":["S0953620526000683"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106763","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pitfalls of autoimmune serological markers and practical diagnostic workflows in connective tissue diseases and rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106763"}}